Targeted Forceps Biopsy for Colorectal Tumors
Not Applicable
- Conditions
- Colorectal Neoplasms
- Registration Number
- NCT03604237
- Lead Sponsor
- Kyungpook National University Hospital
- Brief Summary
This study evaluates whether targeted forceps biopsy with careful tumor surface evaluation can improve diagnostic accuracy of colorectal tumors larger than 2 cm during colonoscopy.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 64
Inclusion Criteria
- Patients with colorectal neoplasms of the size larger than 2 cm
Exclusion Criteria
- Patients who deny the participation in the study
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method pathologic diagnosis 7 days The pathologic diagnosis of forceps biopsy is compared with the pathologic diagnosis of resected specimen of the colorectal tumor.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular markers are detected by targeted forceps biopsy in large colorectal tumors to guide treatment?
How does targeted forceps biopsy accuracy compare to standard biopsy for >2cm colorectal tumors?
Which histological or genetic biomarkers predict diagnostic accuracy of targeted forceps biopsy in colorectal neoplasms?
What are the adverse event profiles and management strategies for targeted forceps biopsy in colorectal tumor diagnosis?
How does targeted forceps biopsy influence treatment selection for colorectal tumors compared to other diagnostic methods?
Trial Locations
- Locations (1)
Kyungpook National University Hospital
🇰🇷Daegu, Korea, Republic of
Kyungpook National University Hospital🇰🇷Daegu, Korea, Republic of